Literature DB >> 8605158

Solubilization, partial purification, and affinity labeling of the membrane-bound isoprenylated protein endoprotease.

Y Chen1, Y T Ma, R R Rando.   

Abstract

A previously described [Ma, Y.-T., & Rando, R. R. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 6275-6279] membrane-associated isoprenylated protein endoprotease is important in the processing of isoprenylated proteins terminating with CAAX. The enzyme is of substantial interest because specific inhibitors of it block the processing and functioning of ras in vivo. The enzyme appears to be an integral membrane protein, as it can only be removed from microsomal membranes with detergent. The enzyme is effectively solubilized by the detergent CHAPSO and can be partially purified (approximately 10-fold) by anion ion exchange and size exclusion chromatography. Attempts to further purify the enzyme by other column means, including affinity chromatography, were unsuccessful. The partially purified enzyme is very sensitive to thiol reagents but insensitive to other kinds of protease inhibitors, suggesting that the enzyme is a thiol protease. Potent and specific chloroketone containing affinity labeling agents have been developed. These novel inactivators owe their potency to an S-farnesylcysteine moiety which is recognized by the enzyme. Specific inhibitors of this type should allow for the identification and cloning of this protease, which is important for signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605158     DOI: 10.1021/bi952529s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Photoaffinity labeling of Ras converting enzyme using peptide substrates that incorporate benzoylphenylalanine (Bpa) residues: improved labeling and structural implications.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2011-10-18       Impact factor: 3.641

2.  Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2010-06-12       Impact factor: 3.641

3.  Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease.

Authors:  Annika M Wahlstrom; Briony A Cutts; Christin Karlsson; Karin M E Andersson; Meng Liu; Anna-Karin M Sjogren; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 4.  Therapeutic intervention based on protein prenylation and associated modifications.

Authors:  Michael H Gelb; Lucas Brunsveld; Christine A Hrycyna; Susan Michaelis; Fuyuhiko Tamanoi; Wesley C Van Voorhis; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2006-10       Impact factor: 15.040

5.  Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones.

Authors:  Stephen B Porter; Emily R Hildebrandt; Sarah R Breevoort; David Z Mokry; Timothy M Dore; Walter K Schmidt
Journal:  Biochim Biophys Acta       Date:  2007-03-20

6.  Mutational analysis of the ras converting enzyme reveals a requirement for glutamate and histidine residues.

Authors:  Lisa J Plummer; Emily R Hildebrandt; Stephen B Porter; Victoria A Rogers; Jay McCracken; Walter K Schmidt
Journal:  J Biol Chem       Date:  2005-12-17       Impact factor: 5.157

7.  The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities.

Authors:  C E Trueblood; V L Boyartchuk; E A Picologlou; D Rozema; C D Poulter; J Rine
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  Modulation of the inhibitor properties of dipeptidyl (acyloxy)methyl ketones toward the CaaX proteases.

Authors:  Anne-Marie R Dechert; James P MacNamara; Sarah R Breevoort; Emily R Hildebrandt; Ned W Hembree; Adam C Rea; Duncan E McLain; Stephen B Porter; Walter K Schmidt; Timothy M Dore
Journal:  Bioorg Med Chem       Date:  2010-07-21       Impact factor: 3.641

9.  8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.

Authors:  Idrees Mohammed; Shahienaz E Hampton; Louise Ashall; Emily R Hildebrandt; Robert A Kutlik; Surya P Manandhar; Brandon J Floyd; Haley E Smith; Jonathan K Dozier; Mark D Distefano; Walter K Schmidt; Timothy M Dore
Journal:  Bioorg Med Chem       Date:  2015-11-30       Impact factor: 3.641

Review 10.  Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.

Authors:  Angela Jeong; Kiall Francis Suazo; W Gibson Wood; Mark D Distefano; Ling Li
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-06       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.